AnalystsAllen GongAllen Gong's Stock Forecasts
AnalystsAllen Gong
Sectors:
Industries:
Analyst Ranking
Top 34%
#1554 out of 4563 analysts
Average Return
+5.6%
Win Rate
55%6 out of 11
Risk vs Reward
Poor
Good
Allen Gong's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Transmedics Group IncTMDX | +151.82% | $37.28 | $93.88 | 2022-08-01 - 2023-08-01 | Strong Buy |
Glaukos CorpGKOS | +18.59% | $85.11 | $100.93 | 2023-12-20 - 2024-04-24 | Strong Buy |
Glaukos CorpGKOS | +12.37% | $48.26 | $42.29 | 2022-11-02 - 2022-12-19 | Strong Sell |
Irhythm Technologies IncIRTC | +10.81% | $105.07 | $116.43 | 2024-02-22 - 2024-04-24 | Strong Buy |
Establishment Labs Holdings IncESTA | +7.16% | $45.68 | $48.95 | 2024-02-28 - 2024-04-24 | Strong Buy |
Allen Gong Analyst Color
Get additional color on Allen Gong's coverage of popular stocks
Allen Gong's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Establishment Labs Holdings IncESTA | 2 | Strong Buy | $53.00 | +8.27% | Maintains | 2 months ago |
Transmedics Group IncTMDX | 2 | Strong Buy | $105.00 | +18.14% | Maintains | 2 months ago |
Irhythm Technologies IncIRTC | 4 | Strong Buy | $133.00 | +14.23% | Maintains | 2 months ago |
Glaukos CorpGKOS | 5 | Strong Buy | $91.00 | -9.84% | Upgrades | 4 months ago |
Beauty Health CoSKIN | 3 | Hold | $12.00 | +280.95% | Maintains | a year ago |
Nuvasive IncNUVA | 1 | Hold | $45.00 | N/A | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.